News
New Orange & Purple Book laws increase transparency of patent information for drugs, biologics
20 January 2021
PartnerNew York
Email jason.leonard@hoganlovells.com
Phone +1 212 918 3782
Fax +1 212 918 3100
Practice groupIntellectual Property, Media, and Technology
Jason Leonard has experience in all types of intellectual property law with a special focus on complex pharmaceutical patent litigation.
Jason has years of experience litigating pharmaceutical patents in federal court, including appeals to the Court of Appeals for the Federal Circuit. His technical knowledge includes new drug compounds, enantiomers, polymorphs, drug formulations, and methods of use. He has litigated patents covering oncology drugs, antifungal agents, and oral contraceptives. Jason has also advised clients regarding regulatory exclusivities at the U.S. Food and Drug Administration, including patent term extensions, new chemical and product exclusivities, and the Generating Antibiotic Incentives Now (GAIN) Act.
Before practicing law, Jason worked for six years as a solid-state and analytical chemist at Pfizer. His work included development of analytical methods for drug formulations and synthesis of novel polymorphs and salts of pharmaceutical compounds. He also focused on conducting investigations of complex scientific problems encountered during drug development. Jason is a co-inventor on several solid-state pharmaceutical patents, including patents covering atorvastatin.
Intellectual Property: Patents: Litigation (Full Coverage), Recommended
Legal 500 US
Education
J.D., Franklin Pierce Law Center, 2007
B.S. Chemistry, University of Connecticut, 1998
Bar admissions and qualifications
New York
New Jersey
Court admissions
U.S. Supreme Court
U.S. Court of Appeals for the Federal Circuit
U.S. District Court, District of New Jersey
U.S. District Court, Southern District of New York
U.S. District Court, Eastern District of New York
News
20 January 2021
Press Releases
29 May 2020
Press Releases
02 April 2019
Media Mention
25 February 2019